IL-17a-producing γδT cells and NKG2D signaling mediate bacterial endotoxin-induced neonatal lung injury: implications for bronchopulmonary dysplasia
Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm birth survivors characterized by inflammation, impaired alveolarization and dysmorphic vasculature. Activated IL-17A+ lymphocytes are key drivers of inflammation in preterm infants. We have shown that in immature mice chronic airw...
Main Authors: | Tracy X. Cui, Alexander E. Brady, Ying-Jian Zhang, Chase Anderson, Antonia P. Popova |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1156842/full |
Similar Items
-
An updated review on systemic glucocorticoids in the prevention and treatment of bronchopulmonary dysplasia
by: Xinyi Wang, et al.
Published: (2023-06-01) -
Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
by: Kacie Dillon, et al.
Published: (2023-08-01) -
Factors Influencing Bronchopulmonary Dysplasia: An Eight-Year Study in a Single Tertiary Care Unit in Thailand
by: Pallapa Moolmai, et al.
Published: (2025-02-01) -
Optimizing ventilator support in severe bronchopulmonary dysplasia in the absence of conclusive evidence
by: Audrey N. Miller, et al.
Published: (2022-11-01) -
Pharmacotherapy in Bronchopulmonary Dysplasia: What Is the Evidence?
by: Rishika P. Sakaria, et al.
Published: (2022-03-01)